1. Home
  2. CCO vs EVO Comparison

CCO vs EVO Comparison

Compare CCO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

SELL

Current Price

$2.41

Market Cap

1.2B

ML Signal

SELL

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.72

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
EVO
Founded
1995
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
994.5M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
CCO
EVO
Price
$2.41
$2.72
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$2.12
$7.00
AVG Volume (30 Days)
7.7M
27.1K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
N/A
EPS
N/A
N/A
Revenue
$1,604,140,000.00
N/A
Revenue This Year
$5.35
$1.37
Revenue Next Year
$4.26
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
6.57
N/A
52 Week Low
$1.00
$2.31
52 Week High
$2.43
$4.42

Technical Indicators

Market Signals
Indicator
CCO
EVO
Relative Strength Index (RSI) 53.57 42.07
Support Level $2.37 $2.63
Resistance Level $2.41 $3.75
Average True Range (ATR) 0.01 0.07
MACD -0.00 -0.02
Stochastic Oscillator 75.00 20.41

Price Performance

Historical Comparison
CCO
EVO

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: